Our Company l News & Events

Ikonisys to Present at the Jefferies 2010 Global Life Sciences Conference

Ikonisys, Inc. announced today that Dr. Petros Tsipouras, Chairman and Chief Executive Officer, will present at the Jefferies 2010 Global Life Sciences Conference.

Presentation details are as follows:
Date: Tuesday, June 8, 2010
Time: 4:30pm Eastern Daylight Time
Location: The Grand Hyatt, New York

About Ikonisys
Founded in 1999, Ikonisys, Inc. is a privately-held, next-generation diagnostic company specializing in non-invasive, cell-based diagnostics. Ikonisys has developed the CellOptics® platform, a robotic microscopy technology for fully-automated, high-throughput identification and analysis of rare cells by fluorescence in-situ hybridization (FISH).

A pipeline of applications is being developed for cancer diagnosis and management (oncoFISH®) and a non-invasive prenatal screening test for Down Syndrome (fastFISH® fetal) to be run on the Ikoniscope using the CellOptics technology. Ikonisys has also developed a novel approach for the enrichment, identification and characterization of circulating tumor cells (CTCs).

Ikonisys' first proprietary test, oncoFISH cervical, is offered as a Laboratory Developed Test through the company's CAP-accredited clinical laboratory. In addition to oncoFISH cervical, the company offers FDA-cleared applications that automate certain commercially available FISH tests.

Media Contact:
Alex Salvi
Renee Maher
Ikonisys
203-776-0791
press@ikonisys.com

Investor Relations Contact:
Louise Mawhinney
Ikonisys
203-776-0791
corporate@ikonisys.com